HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mathias Bähr Selected Research

Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis)

8/2005Limited protection of TAT-Bcl-X(L) against pneumolysin-induced neuronal cell death.
12/2002Neurotoxicity of pneumolysin, a major pneumococcal virulence factor, involves calcium influx and depends on activation of p38 mitogen-activated protein kinase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mathias Bähr Research Topics

Disease

47Stroke (Strokes)
05/2022 - 11/2002
47Parkinson Disease (Parkinson's Disease)
01/2022 - 04/2006
18Brain Ischemia (Cerebral Ischemia)
12/2020 - 05/2003
16Inflammation (Inflammations)
01/2022 - 08/2003
15Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 08/2005
14Ischemia
11/2021 - 11/2002
12Ischemic Stroke
05/2022 - 10/2003
12Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
11/2016 - 08/2003
12Optic Neuritis (Retrobulbar Neuritis)
03/2014 - 10/2004
11Brain Injuries (Brain Injury)
01/2021 - 01/2004
8Infarction (Infarctions)
10/2017 - 04/2006
7Neoplasms (Cancer)
01/2021 - 03/2006
6Optic Nerve Injuries
01/2019 - 03/2002
6Multiple Sclerosis
11/2016 - 02/2005
5Dementia (Dementias)
01/2022 - 06/2013
5Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2020 - 10/2002
5Disease Progression
09/2017 - 11/2006
5Body Weight (Weight, Body)
01/2017 - 05/2006
4Synucleinopathies
01/2022 - 06/2013
4Alzheimer Disease (Alzheimer's Disease)
12/2021 - 06/2013
4Nervous System Diseases (Neurological Disorders)
01/2019 - 09/2002
3Neuroinflammatory Diseases
01/2022 - 05/2004
3Infections
06/2015 - 01/2015
3Neuroblastoma
02/2008 - 12/2002
3Wounds and Injuries (Trauma)
04/2006 - 05/2004
2Traumatic Brain Injuries (Traumatic Brain Injury)
12/2021 - 02/2002
2Sepsis (Septicemia)
01/2021 - 05/2006
2Brain Neoplasms (Brain Tumor)
01/2021 - 03/2006
2Vertebrobasilar Insufficiency
03/2018 - 05/2017
2Rheumatoid Arthritis
01/2018 - 05/2011
2Central Nervous System Diseases (CNS Diseases)
01/2018 - 01/2015
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
03/2017 - 08/2013
2Spinal Cord Injuries (Spinal Cord Injury)
07/2015 - 03/2015
2Demyelinating Diseases (Demyelinating Disease)
03/2014 - 04/2011
2Multiple System Atrophy
07/2013 - 06/2013
2Prion Diseases (Transmissible Spongiform Encephalopathies)
06/2013 - 11/2004
2Seizures (Absence Seizure)
07/2010 - 04/2005
2Transient Ischemic Attack
06/2010 - 04/2009
2Glioma (Gliomas)
08/2007 - 03/2006
2Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis)
08/2005 - 12/2002
2Tuberculosis (Tuberculoses)
07/2004 - 01/2004
2Leprosy (Hansen's Disease)
07/2004 - 01/2004

Drug/Important Bio-Agent (IBA)

35Proteins (Proteins, Gene)FDA Link
12/2021 - 09/2002
14SynucleinsIBA
01/2022 - 07/2011
14Myelin-Oligodendrocyte GlycoproteinIBA
11/2016 - 08/2003
9Neuroprotective AgentsIBA
05/2022 - 01/2004
9Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
11/2018 - 05/2003
8Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2008
8Pharmaceutical PreparationsIBA
01/2021 - 07/2004
8rho-Associated KinasesIBA
01/2020 - 11/2012
71- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
02/2020 - 05/2006
6CytokinesIBA
12/2021 - 03/2007
6Oxygen (Dioxygen)IBA
11/2021 - 01/2006
6Nerve Growth Factors (Neurotrophins)IBA
08/2021 - 02/2002
5Glucose (Dextrose)FDA LinkGeneric
11/2021 - 01/2006
5fasudil (AT 877)IBA
01/2020 - 11/2012
5Prion ProteinsIBA
01/2014 - 11/2004
4IronIBA
12/2021 - 03/2012
4HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
12/2021 - 06/2012
4LithiumIBA
12/2021 - 03/2017
4alpha-SynucleinIBA
01/2020 - 06/2007
4Tissue Plasminogen Activator (Alteplase)FDA Link
01/2017 - 10/2003
4Caspase 3 (Caspase-3)IBA
01/2017 - 04/2005
41-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA
11/2012 - 07/2004
4Granulocyte Colony-Stimulating Factor (G-CSF)IBA
06/2012 - 05/2006
3Transcription Factors (Transcription Factor)IBA
08/2021 - 01/2008
3MicroRNAs (MicroRNA)IBA
08/2021 - 08/2013
3Proteasome Endopeptidase Complex (Proteasome)IBA
10/2017 - 11/2013
3CalciumIBA
12/2015 - 07/2009
3ErythropoietinFDA Link
08/2012 - 02/2005
3Retinaldehyde (Retinal)IBA
01/2012 - 05/2004
3MelatoninIBA
11/2006 - 03/2002
2tau Proteins (tau Protein)IBA
12/2021 - 01/2016
2Apoptosis Regulatory ProteinsIBA
12/2021 - 02/2008
2Fingolimod Hydrochloride (FTY720)FDA Link
01/2021 - 04/2011
2Evans Blue (Blue, Evans)FDA Link
01/2021 - 12/2020
2RE1-silencing transcription factorIBA
03/2017 - 08/2013
2Calcium Channels (Calcium Channel)IBA
01/2017 - 07/2009
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2015 - 06/2015
2Small Interfering RNA (siRNA)IBA
07/2015 - 01/2015
2Anti-Bacterial Agents (Antibiotics)IBA
06/2015 - 01/2004
2flupirtineIBA
06/2015 - 11/2008
2RotenoneIBA
03/2015 - 06/2009
2Amyloid (Amyloid Fibrils)IBA
01/2015 - 05/2008
2Proteasome InhibitorsIBA
10/2014 - 11/2012
2BSc2118IBA
10/2014 - 11/2012
2Oxidopamine (6 Hydroxydopamine)IBA
08/2014 - 06/2009
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2012 - 01/2008
2Bromodeoxyuridine (BrdU)IBA
06/2010 - 06/2009
2Interferon-betaIBA
11/2008 - 10/2006
2Interleukin-1beta (Interleukin 1 beta)IBA
05/2008 - 01/2008
2Streptococcus pneumoniae plY proteinIBA
08/2005 - 12/2002
2MethylprednisoloneFDA LinkGeneric
02/2005 - 08/2003

Therapy/Procedure

35Therapeutics
05/2022 - 09/2002
8Transplantation
11/2021 - 10/2010
5Thrombectomy
05/2021 - 11/2017
3Intravenous Injections
01/2014 - 03/2006
2Ischemic Postconditioning
01/2018 - 10/2017
2Injections
08/2014 - 11/2012
2Thrombolytic Therapy
11/2012 - 06/2012